The Healthcare practice at MarketsandMarkets is pleased to announce its Presentation on the “Radiotherapy Market by Technology, Applications & Products (2011-2016) – Global Trends & Competitive Analysis”
This device market encompasses devices for external beam radiation therapy (CyberKnife, Gamma Knife, TomoTherapy, electron emitting high energy linear accelerators, proton therapy systems etc), brachytherapy (seeds, applicators-afterloaders and electronic brachytherapy) and systemic radiation therapy (Iodine-131, Samarium-153, Rhenium-186, Erbium-169, etc.). This market was valued at $4.4 billion in 2011 and is expected to reach $5.8 billion by 2016, at a CAGR of 5.3% from 2011 to 2016.
The radiotherapy market has witnessed dramatic technological evolutions since the last few years. Every new technique came up with better solution to compensate the procedural gap of the last technique.
The trend in various geographical markets is shaping differently with its unique pace. Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. A considerable amount of clinical research data on the better clinical outcomes through this new therapy is driving the demand of the novel radiotherapy devices. U.S., Europe and Japan have been the pioneer in this medical revolution.
The worldwide radiotherapy market including external beam therapy devices, internal radiotherapy devices and systemic radiation therapy devices is principally commanded by major multinationals, such as Varian Medical System, Accuray, Inc., Elekta AB, Nordion, etc.
The agenda for the briefing includes discussion on key high growth markets, marking the growth trend in radiotherapy devices market. Furthermore, a briefing will be conducted on the competitive scenario, geographical trends and opportunities with focus on geographies such as North America, Europe, Asia, and Rest of the world including Japan.
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252